Search

everythinglearnresearchcommunity

for

Search:↓

Genetics and hormones cause hair loss; finasteride treats it safely.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Using both vertical and transverse sections gives a better diagnosis of alopecia than using one method alone.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Edible seeds from the Cucurbitaceae family like pumpkin and watermelon seeds are nutritious and may have health benefits, but eating too much can cause side effects.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Different types of fibroblasts play various roles in both healthy and diseased tissues, and understanding them better could improve treatments for fibrotic diseases.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Choosing the right shampoo for your hair type is crucial.

The conclusion is that fat grafting is safe and effective but carries risks that need careful management.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

The article concludes that advancements in hair cosmetics require dermatologists to stay informed about products and their potential risks, including allergies and higher risks for hairdressers.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Distinct β-catenin patterns are linked to cell growth, not cell death, in lung cancer.